BJDX

MKT CAP:$888532

Bluejay Diagnostics, Inc.

Market Cap

$888532

Healthcare·Medical - Devices·🇺🇸 United States·NASDAQ

Healthcare·Medical - Devices·🇺🇸·NASDAQ

Stock Price

$2.00-$0.62 (-23.66%)

Apr 22, 2026

Company Details

Bluejay Diagnostics, Inc. operates as a medical diagnostics company. The company offers the Symphony platform, a technology platform comprising the Symphony analyzer that orchestrates whole blood processing, biomarker isolation, and immunoa...

CEO

Indranil Dey

IPO Date

Nov 10, 2021

Website

bluejaydx.com

Key Metrics TTM

Revenue

$0

-100.0% YoY

Net Income

-$7M

EPS (Diluted)

-$58.61

Free Cash Flow

-$6M

Revenue / Share

$0.00

Gross Margin

—

Operating Margin

—

Net Margin

—

FCF Margin

—

P/S

—

P/E

—

Earnings Reports

Q1 2026

May 13, 2026

PENDING

FY 2025

Mar 6, 2026

$0EPS -$15.25

Q4 2025

Mar 6, 2026

$0-100.0%EPS -$2.37

Q3 2025

Nov 7, 2025

$0EPS -$4.04

Q2 2025

Aug 7, 2025

$0EPS -$5.64

Revenue & Profitability

Quarter	Revenue	Gross Profit	Operating Income
Q1 22	$0	-$68.2K	-$2M
Q2 22	$249.0K	$48.9K	-$2M
Q3 22	$0	-$86.7K	-$3M
Q4 22	$0	-$68.9K	-$2M
Q1 23	$0	-$160.3K	-$3M
Q2 23	$0	-$293.5K	-$3M
Q3 23	$0	-$270.8K	-$2M
Q4 23	$1M	$724.6K	-$2M
Q1 24	$0	-$54.3K	-$2M
Q2 24	$0	-$53.7K	-$2M
Q3 24	$0	-$53.6K	-$1M
Q4 24	$216.1K	$108.0K	-$1M
Q1 25	$0	-$51.9K	-$2M
Q2 25	$0	-$38.4K	-$2M
Q3 25	$0	-$31.6K	-$2M
Q4 25	$0	-$48.8K	-$1M

Valuation

Quarter	P/S	P/E
Q1 22	—	—
Q2 22	3.6x	—
Q3 22	3.6x	—
Q4 22	3.6x	—
Q1 23	3.6x	—
Q2 23	—	—
Q3 23	—	—
Q4 23	0.6x	—
Q1 24	0.6x	—
Q2 24	0.6x	—
Q3 24	0.6x	—
Q4 24	4.1x	—
Q1 25	4.1x	—
Q2 25	4.1x	—
Q3 25	4.1x	—
Q4 25	—	—

Operating Cash Flow

Quarter	Operating CF	Free CF
Q1 22	-$2M	-$2M
Q2 22	-$2M	-$2M
Q3 22	-$1M	-$2M
Q4 22	-$3M	-$3M
Q1 23	-$3M	-$3M
Q2 23	-$1M	-$2M
Q3 23	-$1M	-$1M
Q4 23	-$3M	-$3M
Q1 24	-$2M	-$2M
Q2 24	-$2M	-$2M
Q3 24	-$2M	-$2M
Q4 24	-$2M	-$2M
Q1 25	-$1M	-$1M
Q2 25	-$2M	-$2M
Q3 25	-$1M	-$1M
Q4 25	-$1M	-$2M

Capital Expenditures

Quarter	CapEx
Q1 22	$46.3K
Q2 22	$123.3K
Q3 22	$791.5K
Q4 22	$238.2K
Q1 23	$340.7K
Q2 23	$201.1K
Q3 23	$74.5K
Q4 23	$87.9K
Q1 24	$35.4K
Q2 24	$270.0K
Q3 24	$227
Q4 24	$1.1K
Q1 25	$0
Q2 25	$0
Q3 25	$3
Q4 25	$173.7K

CapEx

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q1 22	—	+786.9%
Q2 22	—	+235.5%
Q3 22	—	+193.3%
Q4 22	—	+78.7%
Q1 23	—	+29.6%
Q2 23	-100.0%	+29.9%
Q3 23	—	-16.7%
Q4 23	—	+56.3%
Q1 24	—	-9.4%
Q2 24	—	-34.7%
Q3 24	—	-41.8%
Q4 24	-85.1%	-55.7%
Q1 25	—	-22.2%
Q2 25	—	+4.8%
Q3 25	—	+18.8%
Q4 25	-100.0%	-14.1%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q1 22	$126.1K	—
Q2 22	$106.1K	42.6%
Q3 22	$113.2K	—
Q4 22	$87.6K	—
Q1 23	$219.6K	—
Q2 23	$27.7K	—
Q3 23	-$42.5K	—
Q4 23	-$15.6K	-1.1%
Q1 24	$11.9K	—
Q2 24	$6.0K	—
Q3 24	$4.8K	—
Q4 24	$0	0.0%
Q1 25	$1.3K	—
Q2 25	-$1.6K	—
Q3 25	$0	—
Q4 25	$74	—

OpEx Breakdown

Quarter	R&D	G&A	S&M
Q1 22	$694.8K	$1M	$53.7K
Q2 22	$756.3K	$1M	$81.4K
Q3 22	$1M	$1M	$146.1K
Q4 22	$1M	$961.9K	$170.3K
Q1 23	$1M	$1M	$148.0K
Q2 23	$2M	$1M	$154.3K
Q3 23	$1M	$963.5K	—
Q4 23	$1M	$1M	$687
Q1 24	$1M	$1M	$6.4K
Q2 24	$1M	$862.5K	$305
Q3 24	$551.7K	$809.2K	$753
Q4 24	$554.0K	$929.8K	$816
Q1 25	$784.8K	$1M	—
Q2 25	$889.9K	$1M	—
Q3 25	$785.6K	$831.3K	—
Q4 25	$586.1K	$875.6K	—

War Chest

Quarter	Cash	Short-term Investments	Total
Q1 22	$17M	$0	$17M
Q2 22	$15M	$0	$15M
Q3 22	$13M	$0	$13M
Q4 22	$10M	$0	$10M
Q1 23	$7M	$0	$7M
Q2 23	$5M	$0	$5M
Q3 23	$5M	$0	$5M
Q4 23	$2M	$0	$2M
Q1 24	$3M	$0	$3M
Q2 24	$8M	$0	$8M
Q3 24	$6M	$0	$6M
Q4 24	$4M	$0	$4M
Q1 25	$3M	$0	$3M
Q2 25	$4M	$0	$4M
Q3 25	$3M	$0	$3M
Q4 25	$5M	$0	$5M

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change	YoY Change
Q1 22	31K	+0.1%	+60.0%
Q2 22	31K	+0.0%	+19.9%
Q3 22	31K	+0.0%	+3.3%
Q4 22	32K	+0.3%	+0.5%
Q1 23	32K	+0.8%	+1.2%
Q2 23	32K	+0.4%	+1.5%
Q3 23	34K	+7.8%	+9.5%
Q4 23	39K	+12.3%	+22.6%
Q1 24	37K	-4.0%	+16.7%
Q2 24	37K	0.0%	+16.2%
Q3 24	40K	+7.8%	+16.2%
Q4 24	40K	0.0%	+3.4%
Q1 25	40K	0.0%	+7.8%
Q2 25	347K	+765.7%	+833.2%
Q3 25	394K	+13.5%	+882.7%
Q4 25	449K	+14.1%	+1021.0%

Shares Outstanding

Revenue Per Employee

Period	Revenue/Employee	Employees
Q1 22	$0	9
Q2 22	$27.7K	9
Q3 22	$0	9
Q4 22	$0	16
Q1 23	$0	16
Q2 23	$0	16
Q3 23	$0	16
Q4 23	$144.9K	10
Q1 24	$0	10
Q2 24	$0	10
Q3 24	$0	10
Q4 24	$30.9K	7
Q1 25	$0	7
Q2 25	$0	7
Q3 25	$0	7
Q4 25	$0	6

Revenue / Employee